Taro Pharmaceutical Industries Ltd (NYSE:TARO)

150.92
Delayed Data
As of 4:06pm ET
 -0.08 / -0.05%
Today’s Change
103.33
Today|||52-Week Range
173.00
+1.84%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close151.00
Today’s open151.50
Day’s range149.63 - 153.00
Volume86,344
Average volume (3 months)69,920
Market cap$6.5B
Dividend yield--
Data as of 4:06pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book6.37

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-0.16-0.08%
IDXXIDEXX Laboratories I...-1.29-0.94%
ICPTIntercept Pharmaceut...-5.56-2.13%
SGENSeattle Genetics Inc+0.66+1.55%
Data as of 4:01pm ET, 05/28/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers